TherapeuticsMD (TXMD) Preferred Shares (2012 - 2017)

TherapeuticsMD (TXMD) has reported Preferred Shares for 6 consecutive years, with $10.0 million the latest figure, recorded in Q3 2017.

• For the quarter ending Q3 2017, Preferred Shares changed N/A year-over-year to $10.0 million; the trailing twelve-month figure through Sep 2017 stood at $10.0 million (changed N/A YoY), and the FY2016 full-year result was $10.0 million, changed N/A from the prior year.
• Preferred Shares held at $10.0 million in Q3 2017 per TXMD's latest filing, from $10.0 million in the prior quarter.
• Across five years, Preferred Shares topped out at $10.0 million in Q2 2013 and bottomed at $10.0 million in Q2 2013.
• Historically, Preferred Shares has averaged $10.0 million across 5 years, with a median of $10.0 million in 2013.
• The widest YoY moves for Preferred Shares: up 0.0% in 2013, down 0.0% in 2013.
• Over 5 years, Preferred Shares stood at $10.0 million in 2013, then changed by 0.0% to $10.0 million in 2014, then changed by 0.0% to $10.0 million in 2015, then changed by 0.0% to $10.0 million in 2016, then changed by 0.0% to $10.0 million in 2017.
• According to Business Quant data, Preferred Shares over the past three periods registered $10.0 million, $10.0 million, and $10.0 million for Q3 2017, Q4 2016, and Q2 2015 respectively.